top of page

Search by
Poster
Number

1, 2, 3, 4,
5, 6, 7, 8,
9, 10, 11, 12,
13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66

Poster 28

  • Jun 7, 2023
  • 1 min read

Efficacy and Safety of Monotherapy Amlitelimab, a Non-Depleting Anti-OX40 Ligand Antibody, in Moderate-to-Severe Atopic Dermatitis: 24-Week Results From the Pivotal COAST-1 and COAST-2 Phase 3 Trials


Linda Stein Gold, H. Chih-ho Hong, Pedro Mendes-Bastos, Nina Magnolo, Jinhua Xu, Ken Igawa, Guy Gherardi, Pei Li, Karl Yen, Charlotte Bernigaud, Benjamin Planquette




POSTER 28

 
 
Questions, Comments, and Survey

© DERM2026

bottom of page